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ABSTRACT
Background: According to the WHO, by the 
end of 20 th century, the more the world population 
grow, the more the elderly population will be. 
Yogyakarta province has a 13.72% of Indonesian 
elderly. The anemia prevalence increased as the age 
added. Aging process resulted in strength muscle 
reduced. Handgrip strength test is a valid and 
consistent as well as simple alternative to value the 
muscle strength decreased advanced age. Purpose 
of this study is to know whether anemia is a risk 
factor against muscle strength decreased measured 
by handgrip strength test on elderly population in 
nursing house.
Method: This study used cross sectional 
study design. The study time was in August 2010. The 
advance ages fullfilling the inclusion and exclusion 
criteria followed physical examination, routine 
blood test and handgrip strength measurement.
Result: This study involved 118 elderly 
participants. There was difference of mean handgrip 
strenght in: age (14.52 kg vs 19.64 kg; p=0.001), 
gender (13.39 kg vs 22.47 kg; p=0.001), activity 
level (7.94 kg vs 16.75 kg; p=0.001) and anemia 
status (13.60 kg vs 17.84 kg; p=0.001); for women 
even in mild anemia group, there was difference with 
non anemia group (12.36 kg vs 14.68 kg ; p=0.027). 
Conclusion: According to multivariable 
analysis,. There are 3 factors affecting handgrip 
strength in elderly, namely; Age, activity levels, and 
anemia which are statistically significant. In this 
study, it was concluded that  anemia is a risk factor 
of handgrip strength decreased in elderly, for women 
even in mild anemia, there was statistically 
significant different with non anemia group.
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INTRODUCTION
Based on the World Health Organization 
data on the late twentieth century, the more number 
people in the world, the more number of elderly will 
be, i.e. people with the age 65 years old or more. It's 
also happened in Indonesia, the elderly population in 
2020 will be the fourth largest in the world after 
China, India, and USA. Jogjakarta province 
apparently demonstrated the highest elderly 
1percentage in Indonesia by 13.72% . 
The study in America suggested that anemia 
was the condition frequently found in elderly 
population in society, with prevalence estimation in 
the range of 9 – 18% for male and 8 – 13% for 
female. Whilst in elderly population aged 85 years 
old or more as the most rapidly grow segment of 
elderly population in the whole world, anemia 
2prevalence was even more than 20% . The study in 
Indonesia mentioned that anemia prevalence rate for 
3elderly was 33.3% for male and 10% for female .
Anemia is associated with the decreased of 
balance ability measured objectively, the ability to 
rise up from chair, and the ability to walk fast in 
elderly population aged 71 years old or more. 
Strength muscle measured by handgrip 
dynamometer and muscle mass and density 
measured by quantitative computed tomography 
showed statistically significant lower result in 
4elderly with anemia than that without anemia .
In its following study observing the 
association between anemia and disability, physical 
ability, and muscle strength in elderly who lived in 
Chianti, Italy, total 894 people aged 65 years old or 
more participated in this study. After matching age, 
gender, body mass index, Mini-Mental State 
Examination Score, creatinine level, and various 
comorbid conditions, elderly with anemia 
experienced more disability and worse physical 
ability than elderly without anemia. Elderly with 
anemia also had statistically significant lower 
10
extensor strength of lower leg and lower handgrip 
strength than elderly without anemia. Further 
matching for inflammation markers (interleukin-6, 
C-reactive protein, tumor necrosis factor-á) 
5remained unchanged this association .
By considering that weakness and fatigue 
often become the main complaint on patients with 
anemia, possibly that elderly with anemia 
experienced physical activity decreased as well as 
muscle strength and muscle mass diminished 
resulted from the great reduction of muscle number 
and muscle usage quali ty.  Hemoglobin 
concentration reduction could decrease muscle 
oxygenation, particularly in elderly with vascular 
6disease that ameliorated tissue perfusion disorder . 
Elderly with cardiovascular disease and 
lower hemoglobin concentration, tended to be more 
related with weakness risk elevation or frailty i.e. 
geriatric syndrome characterized by loss body 
weight unintentionally, fatigue, weakness, slower 
movement, and inactive, compared to elderly 
without cardiovascular disease. Other possibility 
was that the association between anemia and much 
decreased physical function in elderly could be seen 
from the increase of inflammation condition or thr 
decrease of testosterone level, factor that could have 
7adverse impact on erythropoiesis and muscle mass .
It can be concluded that aging process will 
cause multiple body physiology decreased, in terms 
of muscle strength decreased in elderly reflected by 
the low handgrip strength and would further 
deteriorate the limitation already exist. Handgrip 
strength test is a valid, consistent, and simple 
alternative to asses muscle strength associated with 
motoric limitation, related to the attempt generally 
done by elderly during the daily activities. It can 
even predict the elderly health such as mortality and 
various limitations accompanying aging process 
itself.
METHOD
The method used in this study was cross 
sectional by assessing muscle strength through 
measuring handgrip strength in elderly population at 
nursing house for elderly. The inclusion criteria: all 
elderly at Panti Werdha in Jogjakarta province's who 
were independent, age 60 years old either male or 
female, and willing to participate in this study. 
Exclusion criteria: stroke history with motoric 
disorder on extremities, fracture history on upper 
extremities bone system, and rheumatoid disease.
RESULT AND DISCUSSION
There were 118 elderly eligible as sample in 
this study. Elderly subjects were given explanation 
about blood sample collection procedure and hand 
grip strength measurement by  handgrip 
dynamometer, then it was performed hand grip 
strength measurement assessment. During the 
assessment, there was no subject failed to 
accomplish the measurement or excluded from the 
study. 
The distribution of 118 elderly studied is 
shown in table 1. Based on age category, it was found 
82 (69.5%) subject proportions with age of 60 – 69 
years old, 36 (30.5%) subject proportions with aged 
70 years old. Female proportion in this study was 
more than male proportion respectively by 83 
(70.3%) vs. 35 (29.7%). Nutrition status proportion 
with IMT 18.5 kg/m2 was 108 (91.5%), while IMT 
18.6 kg/m2 was 10 (8.5%) subjects. Based on 
activity level category, moderate activity level 
proportion was bigger by 109 (92.4%) than low 
activity by 9 (7.6%). In this study, non anemia 
proportion was greater by 69 (58.5%) subjects than 
the subjects having anemia by 49 (41.5%).
Table 1. Basic Characteristic of Study Subjects
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Table 2. The Difference of Mean Handgrip 
Strength Based on Subject Characteristic
* Showed statistically significant difference p < 0.05
* Mann Whitney test
  
Table 2 demonstrated that of 118 subjects 
studied, there was statistically significant difference 
in mean handgrip on category of age, gender, 
activity level, and anemia status (p< 0.05). Based on 
age category, mean handgrip strength at the age of 
60 – 69 years old or more was greater than the age of 
70 years old (19.64 ± 6.74; 14.52 ± 6.23, p = 0.001).
In this study, male group had greater mean 
handgrip strength than female group (22.47 ± 7.63; 
13.39 ± 4.11, p = 0.001). Based on activity level 
category, the group with moderate activity level had 
greater mean handgrip strength compared to the 
group with low activity (17.84 ± 6.21; 13.60 ± 6.21; 
p = 0.001). Mean handgrip strength on anemia 
group was lower than that of non anemia group 
(13.60 ± 6.21; 17.84 ± 6.67; p = 0.001). This result 
was similar with the study performed on 894 
subjects and found that mean handgrip strength on 
anemia was lower than that of non anemia (27.5 ± 
11.6; 21.8 ± 10.4; p = 0.001). In this study, there was 
no statistically significant difference mean hand 
5grip strength (p = 0.721) on nutrition status .
The study of 231 elderly in population 
identified age as independent determinant on 
handgrip strength. The age getting older was 
recognized negatively close associated with 
handgrip strength, the older people, the lower 
handgrip strength would be. Muscle strength and 
muscle mass were also reduced as the age adds 
11particularly because of muscle fiber decreased . 
The decrease in muscle usage became one of the 
strength diminish causes as the time running, which 
was a secondary effect from worse health on elderly 
10.
Male had greater handgrip strength than 
female Gender difference could not completely be 
explained by muscle mass because woman had 
statistically significant lower strength per cm2. 
Better physical ability on male was found in all age, 
however in elderly population, lower physical 
ability on female might be explained by morbidity 
resulted from the reduction of physical activity level 
10on female .
Higher hemoglobin level was found to be 
related with better appearance and muscle strength. 
Considering fatigue frequently became the main 
complaint of anemia patient, possibly that elderly 
with anemia had a decrease in physical activity and 
diminish of muscle strength and muscle mass due to 
disuse. Hypothesis suggested that a decrease in 
hemoglobin concentration would reduce muscle 
5oxygenation .
An analysis is performed for mean 
difference in handgrip strength on male subject with 
mild anemia and non anemia. The result showed that 
male subject with mild anemia had no statistically 
significant mean handgrip strength compared to 
male subject without anemia (19.66 ± 6.04; 23.45 ± 
7.47; p = 0.245), while the analysis of mean 
difference in handgrip strength on female subject 
with mild anemia and non anemia female 
demonstrated that female with mild anemia had 
lower mean handgrip strength than female subject 
without anemia (12.36 ± 3.46; 14.68 ± 3.50, p = 
0.027), as seen in Table 3 and 4.
Table 3. The difference of mean handgrip 
strength on male group with mild anemia 
vs. male group without anemia













*Mild Anemia 10-13 gr%
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Table 4. The difference of handgrip strength 
on female group with mild anemia 
vs. female group without anemia
*Mild Anemia 10-13 gr%
Further analysis was conducted toward 
anemia based on low, moderate, and high 
anemia level, between male and female group. 
The study result demonstrated that there was 
not found the statistically significant difference 
between male and female group based on 
anemia level (p = 0.927 and p = 0.549). This 
result could be found at Table 5. This result was 
different with the study performed in USA, 
which found statistically significant difference 
between low, moderate, and high level anemia 
5(p = 0.01) .
Table 5. The difference of mean handgrip 
strength based on anemia level
Table 6. Multivariate analysis on factors 
influencing handgrip strength
* showed the statistically significant difference p < 0.05
S.E: Standard Error
From multivariate analysis, it was found 
that higher activity level would contribute on 
greater handgrip strength by 7.1 kg compared to 
lower activity level (p = 0.001), for every 1 gr/dl 
hemoglobin elevation would contribute on greater 
handgrip strength by 3.1 kg (p = 0.008). At the age 
category, for every 1 year addition would reduce 
handgrip strength by 164 gram (p = 0.012). The 
result demonstrated that activity level would have 
greatest effect on handgrip strength (Beta= 0.279).
This suggested that activity level must also 
become concern on elderly. It was reported that 
exercise habit on elderly could prevent or slower the 
functional capacity decreased or diminished. 
Prospective study also proved that functional 
dependent on inactive elderly would increase 40 – 
160% compared to physically fit and active elderly .
Considering that factor influencing 
handgrip strength which could be change in this 
study was anemia factor, thus it became very 
important to monitor that condition in elderly. 
Functional ability measured by muscle strength 
measurement using handgrip strength test might be 
parameter describing physical appearance on 
elderly.
CONCLUSION AND SUGGESTION
Anemia is a risk factor of handgrip strength 
decreased in elderly, particularly in female elderly 
with anemia even categorized as mild anemia, and 
there was statistically significant difference from 
female group without anemia. Age and activity 
levels are also risk factors of handgrip strength 
decreased according to multivariable analysis.
We suggest that :
1. Long term study about the association between 
handgrip strength and survival or mortality on 
elderly at Panti Werdha DIY province is warranted.
2. A long term study about correction effect toward 
anemia on elderly on handgrip strength of post 
correction anemia is needed.
3. Further studies including other factors 
influencing handgrip strength are needed. Such 
factors including muscle mass measurement using 
DEXA (Dual-Energy X-ray Absorptiometry) to 
asses muscle mass reduction generally occurred in 
elderly, or depression which is also recognized 
influencing handgrip strength.
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ABSTRACT
Background. Renal dysfunction is a serious 
problem and it provides a poor prognosis for 
patients with advanced liver cirrhosis. This 
condition can progress to kidney failure, which is 
known as hepatorenal syndrome. Cystatin C 
utilization as a marker of decreased kidney function 
in patients with liver cirrhosis has been widely 
proven. Data on how far the severity of liver 
cirrhosis can affect the decline in renal function has 
not been widely known. 
Objective. This study aimed is to verify 
correlation between the severity degree of the liver 
(Child Pugh/CP score) with levels of Cystatin C 
serum. 
Methods. This study was a cross sectional 
study. Population studied were patients with liver 
cirrhosis who visited the clinic of Gastroentero-
hepatology and treated in the Department of 
Internal Medicine ward Dr. Sardjito Hospital - 
Yogyakarta during October 2009 - March 2010. 
Data were analyzed with a computer; the analysis of 
the CP score correlation with increased levels of 
Cystatin C using Spearman correlation for data not 
normally distributed. 
Result. We found 48 research subjects 
during the month of October 2009 - March 2010. The 
subjects were 35 male (72.9%) and 13 female 
(27.1%) with average age 53.1 ± 11.9 years old. 
Subjects with CP-A were 9 patients (18.8%), CP-B 
were 14 patients (29.2%) and CP-C were 25 patients 
(52.1%). The range value of Cystatin C between CP 
class shows CP-A  0.7 - 0.97 mg/L, CP-B 0.7 - 0.49 
mg/L, and CP-C 0.7 – 2.49 mg/L (statistically 
significant difference with p <0.05). Liver cirrhosis 
patients who had Cystatin C levels <0.96 mg/L were 
22 patients (45.83%) and 26 patients (54.1%), had 
higher levels of Cystatin C> 0.96 mg/L. Child score 
was positively correlated to increased levels of 
Cystatin C (p= 0.000; r= 0.566) linear regression 
equation with Cystatin was = 0.37 + 0.08 * Child 
score (r square 0.32). 
Conclusion. This study concluded that the 
Child score had a moderate positive correlation with 
Cystatin C serum level. 
Key words: Liver Cirrhosis – Child Pugh score - 
Cystatin C
INTRODUCTION
Chronic liver disease and cirrhosis cause 
350,000 deaths annually in the United State of 
America (USA). Cirrhosis is the ninth leading cause 
of death in the USA and was responsible for 1.2% of 
all deaths. Patients who have liver cirrhosis aged 
between fifth and sixth decades. In Indonesia, with a 
total estimated population of 238,452,952 people, 
the number of people who suffer from liver cirrhosis 
2  is estimated about 350,666 . In Yogyakarta, the 
number of hospitalized patients with cirrhosis 
ranges from 4.1% of all patients treated in the 
3Internal Medicine ward by the year 2004 . 
Cirrhosis is the final process of liver cells 
injury that turned into a form of fibrosis and nodular 
regeneration in almost all liver cells. Cirrhosis is a 
serious disease and generally is irreversible and in 
the USA, it included 10 largest cause of death. 
Arising clinical signs are the result of liver cell 
dysfunction, and portal hypertension portosistemik 
4shortcut . 
Some of the scoring system used to assess 
the severity of the disease and determine the 
prognosis in patients with cirrhosis. Child Pugh (CP) 
score is based on the severity of disease according to 
the signs, symptoms and laboratory examination 
results, this score proved to be able to predict the 
5survival rate .
Various kinds of complications can occur in 
patients with liver cirrhosis. Hepato-renal syndrome 
(HRS) occurs in approximately 4 of 10,000 patients 
with heart disease, such as acute liver failure, liver 
cirrhosis, or alcoholic hepatitis. Reported mortality 
16
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rates from an HRS were greater than 95% with an 
6average survival less than two weeks .
Renal dysfunction is a serious problem in 
patients with advanced liver cirrhosis, where 
patients with liver cirrhosis accompanied by ascites 
can cause kidney failure, a condition known as 
7  Hepato-renal syndrome . The declined in renal 
function in patients with liver cirrhosis, showed a 
poor prognosis. A prospective cohort study prove 
that in patients with cirrhosis, HRS type I has median 
survival rates 1.7 weeks and only 10% of patients 
survive more than 10 weeks, while in HRS type II 
survival rate reached 50% in first 5 months and 20% 
8in the first .
Creatinine, based on calculation of filtration 
glomerolus showed limitations in predicting GFR in 
patients with cirrhosis. Creatinine clearance have a 
higher estimation in estimating true GFR up to 200% 
9  . Cystatin C (cys C), is a non-glycosylated 13 kDa 
protein that is expected to predict the decline in GFR 
in patients with cirrhosis. Cystatin C is not 
influenced by age and body mass so that the 
measurement of Cystatin C is recommended to 
detect renal insufficiency in patients with liver 
9  cirrhosis . Increased Cystatin C proved to have 
significant correlation to the decline glomerolus 
filtration rate (r -0.85, p <0.001) than creatinine (r -
0.32, p <0.05) in patients with liver cirrhosis. 
Calculation of Cystatin C in patients with cirrhosis 
of the liver is not affected by age or body mass index 
10  . A liver cirrhosis accompanied by ascites and 
normal creatinine levels, Cystatin C concentration 
calculation proved to be as a prognostic marker of 
11future occurrence of HRS .
Due to the nature of reversible renal 
dysfunction in patients with liver cirrhosis, on this 
occasion we want to know any correlation between 
Child score with the levels of Cystatin C in patients 
with liver cirrhosis, and factors that significantly 
influence to the worsening of kidney function, so 
hopefully with this knowledge we can prevent the 
occurrence of an HRS in patients with liver cirrhosis. 
METHODS
This study was a cross-sectional study, with 
the aims of determining whether there was a 
correlation between Child Pugh score with Cystatin 
C levels in the blood. This research was conducted in 
the gastroentero-hepatologist clinic and internal 
medicine ward of Dr. Sardjito Hospital Yogyakarta 
during October 2019 - March 2010. 
Target populations were those who suffer 
from liver cirrhosis who visited at Dr. Sardjito 
Hospital Yogyakarta. Inclusion criteria were: 
Patients with liver cirrhosis, aged 18 years or older, 
and signed inform consent. Exclusion criteria were: 
Patients with heart failure or cardiac cirrhosis, 
patients with renal failure, sepsis, hepatocellulare 
carcinoma, long-term steroid use, thyroid 
dysfunction, hypertension and diabetes mellitus.
Patients who meet inclusion and exclusion 
criteria underwent anamnesis, physical and 
laboratory examination (albumin, bilirubin, 
prothrombin time, creatinine, urea nitrogen, INR, 
Cystatin C) and liver ultrasound. Patients were 
divided into two groups: those with normal levels of 
Cystatin C <0.96 and those with higher levels of 
Cystatin C> 0.96 and then we measured the factors 
that relate to differences in the levels of Cystatin. 
Data were analyzed with a computer; we analyze the 
child score correlation with increased levels of 
Cystatin C using the Pearson correlation for 
normally distributed data and Spearman correlation 
for data not normally distributed. 
RESULTS
During six months of research, 48 patients 
(male 72.9% and female 27.1%) who met the criteria 
for exclusion or inclusion were enrolled in the study. 
Based on Child criteria, there were 9 patients 
(19.8%) with Child A, 14 patients (29.2%) with 
Child B, and 25 patients (52.1%) with Child C. The 
average score of Child was 9.56  ± 2.7 and the 
average of age was 53.1 ± 11.9 years old. Most of the 
subjects had history of Hepatitis B (23 patients; 
47,0%)
Table 1.  Baseline characteristics of 
subjects (total subjects 48)
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Table 3. Child score component 
relationships and Cystatin C levels
In table 3, shows correlation between 
factors (components) in CP criteria to the level of 
Cystatin C (p: 0.000; r: 0.566). Albumin, total 
bilirubin and INR have a correlation of the levels of 
Cystatin C with the p value was significant (p 
<0.05). Levels of albumin with higher levels of 
Cystatin C had a weak negative correlation. Total 
bilirubin levels with higher levels of Cystatin C had 
a positive correlation (r: 0.501). INR levels with 
levels of Cystatin C had a strong positive correlation 
(r: 0.622).
Table 4. Multivariate analysis of liner-
related factors
From the scatter plot diagram, we obtained 
linear equations of Cystatin = 0.37 + 0.08 * Child 
Score with R-Square 0.32. After using multivariate 
analysis on serum albumin, bilirubin total INR and 
the degree of encephalopathy (table 4), note that the 
total bilirubin level and INR were the two factors 
most associated with elevated levels of Cystatin C, 
with linear equation = 0.82 + 0.04 * + 0.08 * total 
bilirubin INR (adjusted r square 51.8%).
DISCUSSION
In this study, we found the prevalence of 
child C liver cirrhosis to be more frequent than other 
groups 25 (52.1%) people. This is possible because 
the sampling was done at the hospital. Previous 
research conducted at the hospital about the 
mortality of patients based on the degree of severity 
of liver found the number of patients with Child C 
11liver cirrhosis who were treated as much as 54% .
The number gender shows males more than 
females (72.9% vs.27.1%). This was almost similar 
to a study conducted in Mexico, where the number 
of patients who underwent liver cirrhosis reached 
25% of the total patients admitted in internal 
12medicine, with the proportion of male - female 3: 1 . 
The role of gender on the incidence of liver cirrhosis 
has some differences based on the etiology and age. 
Liver cirrhosis caused by alcohol makes a 
comparison male – female range from 1.5 to 3:1, 
whereas in primary billiary cirrhosis in women has a 
higher incidence. In liver cirrhosis caused by viral 
infection, a comparison of men and women at age 
less than 35 years and more than 65 years had no 
significant difference, but at age 35-65 years the 
number of men who suffer from cirrhosis of the liver 
caused by previous hepatitis virus infection is higher 
than women 3 to 4 : 1. This is apparently due to the 
influence of estrogen in women who have a 
protective effect against the occurrence of liver 
13  cirrhosis . The average of age with cirrhosis in this 
study were 53.1±11.9 years.  Based on 
epidemiological data, cirrhosis of the liver is usually 
suffered by those who entered the age of five or six 
decade. 
Patients with a history of liver cirrhosis with 
hepatitis B, the most widely encountered in this 
study were as many as 47.9%. This result is similar 
to a study conducted in Ghana on the prevalence of 
viral hepatitis among patients with liver cirrhosis. In 
their study, they found the prevalence of positive 
HBsAg was 42.9%, where OR for the occurrence of 
cirrhosis 8.07 (p: 0.000). HCV is responsible for 
7.1% of cases with liver cirrhosis but not proved the 
The range value of Cystatin C between CP 
class shows CP-A  0.7 - 0.97 mg/L, CP-B 0.7 - 0.49 
mg/L, and CP-C 0.7 – 2.49 mg/L (statistically 
significant difference with p <0.05) (Figure 1). To 
know the correlation between the degrees of 
severity of the liver to the decline of renal function 
we performed regression analysis as seen in scatter 
diagram on figure 2. 
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existence of a significant relationship between the 
14incidence of cirrhosis itself .
Cystatin C levels increased above normal 
values, obtained in liver cirrhosis Child B. In 
previous studies, elevated levels of Cystatin C 
already observed in Child A, although the increment 
was not significant. Elevated levels of Cystatin C 
were more common in those with Child B and C, 
where the increasing in Child C was significantly 
15  higher .
Seo et al. (2009) found that Cystatin C 
concentration is a predictive factor for the incidence 
of HRS. In this study, the patients with liver cirrhosis 
with ascites and normal creatinine where all 
cirrhotic patients with Child B and C. In our 
research, elevated levels of Cystatin C were related 
with degrees of severity. Increased Cystatin C in our 
study started in Child B liver cirrhosis. After 
multivariate analysis with backward method, the 
levels of bilirubin and INR were factors that 
influence the increase in Cystatin C. Evidence that 
the degree of severity of the liver associated with 
elevated levels of Cystatin C can be seen in previous 
studies, which showed an average concentration 
levels of Cystatin C was higher in patients with 
hepatocellular carcinoma patients (1.16±0.1 mg/L) 
compared to patients with liver cirrhosis and 
patients with chronic hepatitis (1.13±0.09 mg/L and 
0.68±0.03 mg/L). Cystatin C concentration was also 
shown to have a correlation with histological degree 
of liver fibrosis stage and levels of total bilirubin, 
16albumin, and platelets . Increased bilirubin and 
INR showed increasing degrees of severity of liver. 
A previous study in patients with primary biliary 
cirrhosis found that levels of bilirubin and 
hyaluronic acid are the two independent variables 
associated with the degree of fibrosis in liver 
cirrhosis. Increased serum bilirubin of 10 mg/dl led 
to increased probability of the widespread degree of 
17cirrhosis by 3.4-fold (p: 0.05, CI 1.0 to 11.2) .
An elongated period of bleeding in patients 
with liver cirrhosis is a reflection of the severity of 
cirrhosis. Elevated levels of bilirubin as a marker of 
the severity of liver shows strong correlation with 
the length of bleeding (ß coefficient 0.19, p = 0.007) 
18.
CONCLUSIONS
Based on the results of this study there were 
positive relationships between Child score with 
elevated levels of Cystatin C. Additional samples 
were collected from similar studies in the future are 
expected to increase the strength of the relationship 
between the severity score of cirrhosis (Child score) 
with decreased renal function (elevated levels of 
Cystatin C). Cystatin C is superior to the detection of 
kidney function than other tools.
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